Financial Reporting
Q3 2023 Financial Statements
Q3 2023 MD&A
Q2 2023 Financial Statements
Q2 2023 MD&A
Q1 2023 Financial Statements
Q1 2023 MD&A
2023 Annual Information Form
2023 Information Circular
2023 Notice and Access Notification
2023 Form of Proxy
Q4 2022 Financial Statements
Q4 2022 MD&A
Q3 2022 Financial Statements
Q3 2022 MD&A
Q2 2022 Financial Statements
Q2 2022 MD&A
Q1 2022 Financial Statements
Q1 2022 MD&A
2022 Annual Information Form
2022 Information Circular
2022 Notice and Access Notification
2022 Form of Proxy
Q4 2021 Financial Statements
Q4 2021 MD&A
Q3 2021 Financial Statements
Q3 2021 MD&A
Q2 2021 Financial Statements
Q2 2021 MD&A
Q1 2021 Financial Statements
Q1 2021 MD&A
2021 Annual Information Form
2021 Information Circular
2021 Notice and Access Notification
2021 Form of Proxy
Q4 2020 Financial Statements
Q4 2020 MD&A
Q3 2020 Financial Statements
Q3 2020 MD&A
Q2 2020 Financial Statements
Q2 2020 MD&A
Q1 2020 Financial Statements
Q1 2020 MD&A
2020 Annual Information Form
2020 Information Circular
2020 Notice and Access Notification
2020 Form of Proxy
Q4 2019 Financial Statements
Q4 2019 MD&A
Q3 2019 Financial Statements
Q3 2019 MD&A
Q2 2019 Financial Statements
Q2 2019 MD&A
Q1 2019 Financial Statements
Q1 2019 MD&A
2019 Annual Information Form
2019 Information Circular
2019 Form of Proxy